Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing ALTROPANE SPECT Imaging in Parkinson's Disease
NCT00397228Phase 2Completed
- Sponsor
- Molecular NeuroImaging
- Start
- Nov 2006
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of altropane in Parkinson's disease (PD), sponsored by Molecular NeuroImaging. Started Nov 2006; status: completed.
02
Drugs
altropane
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00397228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397228.